FRONTAGE LABS

History

YearDetail
2001 Frontage Labs, a testing laboratory in Thorofare focusing on analytical and bioanalytical testing, was founded by Dr. Song Li.
2004 Frontage Labs was incorporated, and laboratory facilities were opened in Pennsylvania.
2012 Frontage Labs expanded by adding DMPK services and relocating its headquarters to Exton, Pennsylvania.
2015 Frontage Labs acquired BDM Consulting, Inc., a contract research organization specializing in data management and biostatistics, to expand its clinical research services.
2018 Frontage Labs acquired Concord Biosciences, formerly known as Ricerca Biosciences LLC, a preclinical CRO, to provide pharmaceutical product development services.
2020 Frontage Labs acquired ACME Biosciences' Discovery Service to expand its synthetic and medical chemistry capabilities and process research & development services.
2021 Frontage Labs acquired Ocean Ridge Biosciences to enhance its ability to provide specialized genomic services to pharmaceutical and life science clients globally. 
2023 Frontage Labs acquired Nucro-Technics Inc., a pharmaceutical contract research organization, to strengthen its presence in Canada.
2024 Frontage Labs acquired Accelera S.r.l.’s Bioanalytical and DMPK Businesses in Italy to expand its operations in Europe.
AI Sentiment